MB, Levis & Associates’s WisdomTree US High Dividend Fund DHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18M Buy
158,666
+421
+0.3% +$46.9K 6.65% 3
2026
Q1
$17.3M Buy
158,245
+1,678
+1% +$182K 7.21% 3
2025
Q4
$15.9M Sell
156,567
-2,584
-2% -$260K 6.71% 3
2025
Q3
$16M Sell
159,151
-680
-0.4% -$67.5K 6.94% 3
2025
Q2
$15.3M Buy
159,831
+435
+0.3% +$40.8K 6.74% 3
2025
Q1
$15.8M Buy
159,396
+761
+0.5% +$73.6K 7.34% 2
2024
Q4
$14.8M Sell
158,635
-1,414
-0.9% -$136K 7.42% 3
2024
Q3
$15M Sell
160,049
-871
-0.5% -$78.5K 7.4% 4
2024
Q2
$13.6M Sell
160,920
-3,560
-2% -$301K 7.16% 4
2024
Q1
$14.3M Sell
164,480
-276
-0.2% -$22.7K 7.65% 3
2023
Q4
$13.5M Buy
164,756
+455
+0.3% +$35.6K 7.75% 3
2023
Q3
$12.8M Buy
164,301
+3,453
+2% +$278K 8.32% 2
2023
Q2
$12.8M Buy
160,848
+735
+0.5% +$58.8K 8.2% 2
2023
Q1
$13.2M Sell
160,113
-46,251
-22% -$3.95M 9.17% 2
2022
Q4
$17.8M Buy
+206,364
New +$17.5M 13.89% 1

Other funds holding DHS

MB, Levis & Associates's DHS Position: Q2 2026 in Review

MB, Levis & Associates increased its WisdomTree US High Dividend Fund (DHS) stake by 0.27% in Q2 2026, buying an estimated $46.9K and bringing the position to 158,666 shares worth $18M. The position accounts for 6.65% of the portfolio, ranked #3.

MB, Levis & Associates first reported a position in DHS in Q4 2022 and has held it in 15 quarters since. 251 funds tracked by Wall St. Rank hold DHS as of Q2 2026.

  • MB, Levis & Associates held 158,666 shares of WisdomTree US High Dividend Fund worth $18M as of Q2 2026.
  • MB, Levis & Associates bought 421 WisdomTree US High Dividend Fund shares in Q2 2026, an estimated $46.9K.
  • WisdomTree US High Dividend Fund made up 6.65% of MB, Levis & Associates's portfolio in Q2 2026, its #3 holding.
  • MB, Levis & Associates first reported a position in WisdomTree US High Dividend Fund in Q4 2022 and has held it in 15 quarters since.
  • 251 funds tracked by Wall St. Rank held WisdomTree US High Dividend Fund as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.